Project Details
Description
Establish the viability of combined IRE and Death Receptor activation (apoptosis) to optimize efficacy of the therapeutic strategy for pancreatic cancer
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/18 → 12/31/18 |
Funding
- BOSTON SCIENTIFIC CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.